Literature DB >> 8419175

Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages.

J A López1, J H LeBowitz, S M Beverley, H G Rammensee, P Overath.   

Abstract

The question is addressed whether antigens of Leishmania, a parasite residing in the endosomal compartment of macrophages, can be presented in the context of major histocompatibility complex class I molecules. We used E. coli beta-galactosidase as a model antigen which can be expressed in high levels in L. mexicana promastigotes (L. mexicana-gal). Infection of BALB/c mice with L. mexicana-gal induces beta-galactosidase-specific cytotoxic T cells (CTL), which can be isolated using a beta-galactosidase-expressing mastocytoma line as an antigen-presenting cell. These CTL recognize epitopes of beta-galactosidase in the context of H-2Kd; however, they do not recognize L. mexicana-gal-infected macrophages even after killing of the intracellular amastigotes by drug treatment or macrophage activation by lymphokines, although class I-peptide interaction and the presentation of endogenously produced antigens is normal. It is concluded that parasite antigens can induce a CTL response in vivo but that these CTL cannot recognize infected macrophages because the relevant epitopes cannot gain access to class I molecules. The effect of priming in vivo may be explained by the well-known but ill-understood phenomenon of cross-priming.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419175     DOI: 10.1002/eji.1830230134

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors:  H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.

Authors:  V Rodrigues; J Santana da Silva; A Campos-Neto
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.

Authors:  Sylvie Bertholet; Alain Debrabant; Farhat Afrin; Elisabeth Caler; Susana Mendez; Khaled S Tabbara; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.

Authors:  M Huber; E Timms; T W Mak; M Röllinghoff; M Lohoff
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Authors:  Rosalind Polley; Simona Stager; Sara Prickett; Asher Maroof; Soombul Zubairi; Deborah F Smith; Paul M Kaye
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 6.  Investigating immune responses to parasites using transgenesis.

Authors:  Mebrahtu G Tedla; Alison L Every; Jean-Pierre Y Scheerlinck
Journal:  Parasit Vectors       Date:  2019-06-15       Impact factor: 3.876

Review 7.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.